Online Intervention for Emotional Reasoning Bias in Public Speaking Anxiety
Emotional Reasoning bias correction training
+ Module of Mindfulness of the Transdiagnostic treatment
Treatment Study
Summary
Study start date: November 1, 2024
Actual date on which the first participant was enrolled.This study focuses on helping individuals who experience anxiety related to public speaking, which is a common issue affecting people's work, education, and social interactions. The study aims to address a specific thinking pattern called Emotional Reasoning bias, which can make it difficult for people to overcome negative thoughts. The goal is to use an online program to train people in recognizing and correcting these biased thought patterns, potentially leading to better management of their public speaking anxiety. This approach is important because it leverages internet-based technologies to make the treatment more accessible to those in need. Participants in the study will be divided into two groups: one receiving the specialized online training and another receiving a general intervention. Each participant will go through 12 daily sessions that involve learning about emotions and identifying how biases affect behavior. The main focus will be on reducing the severity of Emotional Reasoning bias and symptoms related to public speaking anxiety. Additionally, the study will look at changes in depression, anxiety, quality of life, and how easy and acceptable the program is for participants. Assessments will be conducted at the start, after completing the treatment, and again three months later to measure the effectiveness of the intervention.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.158 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalGroup II
Active ComparatorStudy Objectives
Primary Objectives
Secondary Objectives